Read a letter to Functional Pathways employees from Dan Knorr, President.
Our employees’ and clients’ safety and wellbeing is of great importance to us. We continue to closely monitor the Centers for Disease Control and Prevention (CDC) guidelines as well as state and federal government resources. Our Senior Leadership is meeting daily to review new information, trends, and concerns related to COVID-19. We are keeping our staff updated through the distribution of Frequently Asked Questions to all FP employees. We assure you that we are on top of any changes that may occur and any preparation we may need to make. We continue to develop resources, provide education, and communication to you and to our clients and are committed to doing so until we weather this storm.
Supported by the federal Agency for Healthcare Research and Quality (AHRQ), and in collaboration with the Institute for Healthcare Improvement (IHI), Project ECHO is launching
The Occupational Safety and Health Administration (OSHA) released a one-page fact sheet on frequently cited standards related to COVID-19 inspections.
On November 9, 2020, the U.S. Food and Drug Administration issued an EUA for the investigational monoclonal antibody therapy, bamlanivimab, for the treatment of mild-to